KOKishor Vasant Otari

Kishor Vasant Otari

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kishor Vasant Otari has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Chandrashekhar Devidas Upasani

    SNJB’s SSJ College of Pharmacy

    3 shared publications
  • Bhalsing Gaurav Vijay

    Department of Pharmacology, Rajgad Dyanpeeth’s College of Pharmacy, Bhor, Dist: Pune, India-412 206, Maharashtra, India

    1 shared publication
  • Bodhankar Subhash Laxamanrao

    Department of Pharmacology, Poona College of Pharmacy, Bharati Vidyapeeth University, Paud Road, Erandwane, Pune 411 038, Maharashtra, India

    1 shared publication
  • Mali Vishal Ramahari

    Department of Pharmacology, Poona College of Pharmacy, Bharati Vidyapeeth University, Paud Road, Erandwane, Pune 411 038, Maharashtra, India

    1 shared publication
  • Nandgude Tanaji Dilip

    Department of Pharmacology, Rajgad Dyanpeeth’s College of Pharmacy, Bhor, Dist: Pune, India-412 206, Maharashtra, India

    1 shared publication
  • Priyanka Subhash Gaikwad

    Rajgad Dyanpeeth’s College of Pharmacy

    1 shared publication

Latest Publications

  • Involvement of NO–cGMP pathway in anti-hyperalgesic effect of PDE5 inhibitor tadalafil in experimental hyperalgesia

    by K. V. Otari, C. D. Upasani

    The association of elevated level of cyclic guanosine monophosphate (cGMP) with inhibition of hyperalgesia and involvement of nitric oxide (NO)-cGMP pathway in the modulation of pain perception was previously reported. Phosphodiesterases 5 (PDE5) inhibitors, sildenafil and tadalafil (TAD) used in erectile dysfunction, are known to act via the NO–cGMP pathway. TAD exerts its action by increasing the levels of intracellular cGMP. Hence, the present study investigated the effect of TAD 5, 10, or 20 mg/kg, per os (p.o.) or L-NAME 20 mg/kg, intraperitoneally (i.p.) and TAD (20 mg/kg, p.o.) in carrageenan- and diabetes-induced hyperalgesia in rats using hot plate test at 55 ± 2 °C. In carrageenan- and diabetes-induced hyperalgesia, TAD (10 and 20 mg/kg, p.o.) significantly increased paw withdrawal latencies (PWLs) as compared to the control group. L-NAME significantly decreased PWLs as compared to the normal group and aggravated the hyperalgesia. Moreover, significant difference in PWLs of L-NAME and TAD 20 was evident. Co-administration of L-NAME (20 mg/kg) with TAD (20 mg/kg) showed significant difference in PWLs as compared to the TAD (20 mg/kg), indicating L-NAME reversed and antagonized TAD-induced anti-hyperalgesia. This suggested an important role of NO–cGMP pathway in TAD-induced anti-hyperalgesic effect.


  • Protective effect of aqueous extract of Spinacia oleracea leaves in experimental paradigms of inflammatory bowel disease

    by Kishor Vasant Otari, Priyanka Subhash Gaikwad, Rajkumar Virbhadrappa Shete, Chandrashekhar Devidas Upasani

    The present study was aimed to assess the protective effect of aqueous extract of Spinacia oleracea leaves (AESO 250, 500, and 1,000 mg/kg, p.o.) in inflammatory bowel disease using acetic acid- and ethanol-induced colitis in mice and indomethacin-induced enterocolitis in rats. The preliminary phytochemical analysis and further high performance thin layer chromatographic (HPTLC) analysis and phytochemical tests of HPTLC bands confirmed the presence of flavonoids and tannins in AESO. In acute oral toxicity study, administration of AESO (5,000 mg/kg, p.o.) did not show any sign of toxicity and mortality. The treatment with AESO significantly increased body weight, decreased diarrhea with bloody stools, increased blood hemoglobin and plasma total protein, and decreased serum and ileum or colon malondialdehyde content and attenuated the extent of lesions and ameliorated the histological injury of mucosa in all paradigms. The most prominent effects were evident for AESO 1,000 mg/kg. The results of the present study revealed that AESO was effective in attenuating almost all the symptoms of IBD in experimental paradigms. The effect might be due to the antioxidant activity of the flavonoids present in the AESO.


    • 1 January 2012
      • Vol. 11  (2) , 621-34
    Open Access

    Antihypertensive and Diuretic Effects of the Aqueous Extract of Colocasia esculenta Linn. Leaves in Experimental Paradigms.

    by Otari Kishor Vasant, Bhalsing Gaurav Vijay, Shete Rajkumar Virbhadrappa, Nandgude Tanaji Dilip, Mali Vishal Ramahari, Bodhankar Subhash Laxamanrao

    Colocasia esculenta Linn (CE) is traditionally used for the treatment of various ailments such as high blood pressure, rheumatic pain, pulmonary congestion, etc. Hence in present study, the effect of aqueous extract of CE leaves (AECE) was evaluated for antihypertensive and acute diuretic activity in rats. Preliminary phytochemical evaluation revealed the presence of carbohydrate, saponins, tannins, and flavonoids in AECE. The animals did not show any sign of toxicity and mortality after the administration of AECE 2000 mg/Kg in acute oral toxicity study. The administration of AECE (100, 200, and 400 mg/Kg/day, p.o.) for six weeks and AECE (10, 20, and 40 mg/Kg, IV) on the day of experiment in renal artery-occluded hypertensive rats and AECE (20 and 40 mg/Kg, IV) in noradrenalin-induced hypertension in rats produced significant (p < 0.05) anti-hypertensive effects. AECE (400 mg/Kg, p.o.) showed positive diuretic activity at 5 h. AECE (200 and 400 mg/Kg, p.o.) significantly increased sodium and chloride content of urine in 5 h and 24 h and additionally potassium in 24 h urine. Hence, the results of the present study revealed the antihypertensive and weak diuretic activity of AECE. These effects may be attributed due to the ACE inhibitory, vasodilatory, β-blocking, and/ or Ca(2+) channel blocking activities, which were reported for the phytoconstitunts, specifically flavonoids such as vitexin, isovitexin, orientin, and isoorientin present in the leaves of CE.